Research Article

The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience

Volume: 34 Number: 2 May 31, 2021
  • Mehmet Tahtabası
  • Mehmet Kolu
EN

The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience

Abstract

Objective: To evaluate the efficacy of transarterial embolization (TAE) in the treatment of acute upper gastrointestinal bleeding (UGIB) and identify potential factors affecting the treatment outcome. Patients and Methods: Eighteen patients with UGIB treated with TAE were included in the study. The demographic data, causes of bleeding, angiography findings, treatments applied, and clinical outcomes were retrospectively analyzed. Results: Thirteen (72.2%) patients were male, five (27.8%) were female, and the mean age was 55 years (range: 33-68 years). A pseudoaneurysm (n = 7; 38.9%) was the most common finding, followed by tumor staining (n = 4; 22.2%). The most common pathology causing bleeding was peptic ulcer disease (n = 9; 50%). The most commonly embolized artery was the gastroduodenal artery (n = 11; 61.1%). There were three (16.7%) patients with hemobilia due to iatrogenic hepatic artery pseudoaneurysm. In most cases (n = 9; 50%), coils and polyvinyl alcohol particles were used in combination. Technical success was achieved in all patients. The clinical success rate was 78.5% (11/14 patients) after the exclusion of patients who died for non-UGIB causes (n = 4; 22.2%). Conclusion: Transarterial embolizati

Keywords

References

  1. Bua-Ngam C, Norasetsingh J, Treesit T, et al. Efficacy of emergency transarterial embolization in acute lower gastrointestinal bleeding: A single-center experience. Diagn Interv Imaging 2017;98:499-505. doi.org/10.1016/j. diii.2017.02.005.
  2. Augustin AM, Fluck F, Bley T, Kickuth R. Endovascular therapy of gastrointestinal bleeding. RöFo Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgeb Verfahren 2019;191:1073-82. doi.org/10.1055/a-0891-1116.
  3. Chang WC, Liu CH, Hsu HH, et al. Intra-arterial treatment in patients with acute massive gastrointestinal bleeding after endoscopic failure: Comparisons between positive versus negative contrast extravasation groups. Korean J Radiol 2011;12:568–78. doi.org/10.3348/kjr.2011.12.5.568.
  4. Loffroy RF. Recent advances in endovascular techniques for management of acute nonvariceal upper gastrointestinal bleeding. World J Gastrointest Surg 2011;3:89. doi. org/10.4240/wjgs.v3.i7.89.
  5. Pannatier M, Duran R, Denys A, Meuli R, Zingg T, Schmidt S. Characteristics of patients treated for active lower gastrointestinal bleeding detected by CT angiography: Interventional radiology versus surgery. Eur J Radiol 2019;120:108691. doi.org/10.1016/j.ejrad.2019.108691.
  6. Köhler G, Koch OO, Antoniou SA, et al. Relevance of Surgery after Embolization of Gastrointestinal and Abdominal Hemorrhage. World J Surg 2014;38:2258-66. doi.org/10.1007/ s00268.014.2570-7.
  7. Loffroy R, Rao P, Ota S, De Lin M, Kwak B-K, Geschwind J-F. Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol 2010;33:1088-100. doi.org/10.1007/s00270.010.9829-7.
  8. Loffroy R, Guiu B, Mezzetta L, et al. Short – and long-term results of transcatheter embolization for massive arterial hemorrhage from gastroduodenal ulcers not controlled by endoscopic hemostasis. Can J Gastroenterol 2009;23:115-20. doi.org/10.1155/2009/795460.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Mehmet Tahtabası This is me
0000-0001-9668-8062
Türkiye

Publication Date

May 31, 2021

Submission Date

November 25, 2020

Acceptance Date

February 13, 2021

Published in Issue

Year 2021 Volume: 34 Number: 2

APA
Tahtabası, M., & Kolu, M. (2021). The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience. Marmara Medical Journal, 34(2), 180-188. https://doi.org/10.5472/marumj.944254
AMA
1.Tahtabası M, Kolu M. The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience. Marmara Med J. 2021;34(2):180-188. doi:10.5472/marumj.944254
Chicago
Tahtabası, Mehmet, and Mehmet Kolu. 2021. “The Efficacy and Clinical Outcomes of Transarterial Embolization in Acute Massive Upper Gastrointestinal Bleeding: A Single-Center Experience”. Marmara Medical Journal 34 (2): 180-88. https://doi.org/10.5472/marumj.944254.
EndNote
Tahtabası M, Kolu M (May 1, 2021) The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience. Marmara Medical Journal 34 2 180–188.
IEEE
[1]M. Tahtabası and M. Kolu, “The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience”, Marmara Med J, vol. 34, no. 2, pp. 180–188, May 2021, doi: 10.5472/marumj.944254.
ISNAD
Tahtabası, Mehmet - Kolu, Mehmet. “The Efficacy and Clinical Outcomes of Transarterial Embolization in Acute Massive Upper Gastrointestinal Bleeding: A Single-Center Experience”. Marmara Medical Journal 34/2 (May 1, 2021): 180-188. https://doi.org/10.5472/marumj.944254.
JAMA
1.Tahtabası M, Kolu M. The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience. Marmara Med J. 2021;34:180–188.
MLA
Tahtabası, Mehmet, and Mehmet Kolu. “The Efficacy and Clinical Outcomes of Transarterial Embolization in Acute Massive Upper Gastrointestinal Bleeding: A Single-Center Experience”. Marmara Medical Journal, vol. 34, no. 2, May 2021, pp. 180-8, doi:10.5472/marumj.944254.
Vancouver
1.Mehmet Tahtabası, Mehmet Kolu. The efficacy and clinical outcomes of transarterial embolization in acute massive upper gastrointestinal bleeding: a single-center experience. Marmara Med J. 2021 May 1;34(2):180-8. doi:10.5472/marumj.944254

Cited By